Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Cancer

  • sponsor
Updated on 25 March 2021


Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Cancer


The MR-guided ExAblate Focused Ultrasound study is being conducted to assess the safety and effectiveness of an investigational device for the treatment of prostate cancer.

The ExAblate treatment is a focal treatment where a small portion of the prostate is treated, only where the cancer is located.

The study will enroll 100 patients with intermediate risk, localized, organ confined prostate cancer. For most study patients, this study will last for up to 26 – 30 months. If you qualify for the study, you will receive the ExAblate treatment.

This clinical research study will evaluate the safety and effectiveness of ExAblate for the treatment of intermediate risk, localized, organ confined prostate cancer.

If you are eligible, you will receive:
  • The ExAblate treatment at no cost
  • Study-related care from a local study doctor

We encourage you to discuss study participation with your physician, family and friends.

For more information, you may also visit:

Condition Prostate Cancer
Clinical Study IdentifierTX149745
Last Modified on25 March 2021


Yes No Not Sure

Inclusion Criteria

Males age 50 and older
Biopsy proven adenocarcinoma of the prostate
Patient with intermediate risk, early-stage organ-confined prostate cancer and voluntarily chooses ExAblate thermal ablation as the non-invasive treatment, who may currently be on watchful waiting or active surveillance and not in need of imminent radical therapy
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note